Nanosized drug formulations under microfluidic continuous flow
- 15 August 2011
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 11 (19) , 3214-3217
Abstract
We present a simple method involving a rotating tube processor to fabricate ultrafine crystalline drug nanoparticles under microfluidic continuous flow with precise control over particle size, with significantly enhanced dissolution of the drug.Keywords
This publication has 26 references indexed in Scilit:
- Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic studyJournal of Chromatography B, 2007
- Effects of penetration enhancers on in vitro permeability of meloxicam gelsInternational Journal of Pharmaceutics, 2007
- Formulation optimization of meloxicam sodium gel using response surface methodologyInternational Journal of Pharmaceutics, 2007
- Improved absorption of meloxicam via salt formation with ethanolaminesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Investigation of microemulsion system for transdermal delivery of meloxicamInternational Journal of Pharmaceutics, 2006
- Mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with serum albuminJournal of Pharmaceutical and Biomedical Analysis, 2005
- Multifunctional nanorods for gene deliveryNature Materials, 2003
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Inverse targeting of reticuloendothelial system-rich organs after intravenous administration of adriamycin-loaded neutral proliposomes containing poloxamer 407 to ratsInternational Journal of Pharmaceutics, 1996
- Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal toleranceInflammation Research, 1995